Preliminary Results of a Phase II Open-Label Study of Maternal Donor-Derived Cytomegalovirus Cytotoxic T-Lymphocytes and Valganciclovir in Neonates with Moderate/Severe Maternal Acquired CMV Infection

Sydney F. Brannen, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY, United States; Edo Schaefer, Westchester Medical Center, Valhalla, NY, United States; Philippe Friedlich, Keck School of Medicine of the University of Southern California, Los Angeles, CO, United States; Dean Lee, Nationwide Children's Hospital, Columbus, OH, United States; Masako Shimamura, Nationwide Children's Hospital, Columbus, OH, United States; Xiaokui M. Mo, The Ohio State University, Columbus, OH, United States; Yongping Wang, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Laura Vella, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Carol M. Kao, Washington University in St. Louis, St Louis, MO, United States; Shalini Shenoy, Washington University in St. Louis, St. Louis, MO, United States; Suzanne Braniecki, New York Medical College, Hawthorne, NY, United States; Lauren Harrison, New York Medical College, Valhalla, NY, United States; Erin Morris, New York Medical College, Valhalla, NY, United States; Edmund F.. La Gamma, New York Medical College, Valhalla, NY, United States; Mitchell Cairo, New York Medical College, Valhalla, NY, United States